Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
about
Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloningImmunoprevention of chemical carcinogenesis through early recognition of oncogene mutationsDevelopment of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin.Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses.Antigen presentation and DNA vaccines.Novel immune-modulator identified by a rapid, functional screen of the parapoxvirus ovis (Orf virus) genome.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.The antioxidative effect of heat-shock protein 70 in dendritic cells.Targeting epidermal Langerhans cells by epidermal powder immunization.Particle-mediated DNA vaccine delivery to the skin.Microparticles for the delivery of DNA vaccines.Discovery of novel immunostimulants by dendritic-cell-based functional screening.Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses.Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.A role for NF-kappaB-dependent gene transactivation in sunburn.Progress in the development of genetic immunization.Murine and Human Model Systems for the Study of Dendritic Cell Immunobiology.The XS106 cell: a Langerhans' cell surrogate with a selective type 2 phenotype.Mitochondrial ATP synthase is a target for TNBS-induced protein carbonylation in XS-106 dendritic cells.Novel functions of herbal medicines in dendritic cells: role of Amomi Semen in tumor immunity.Functional characterization of recombinant major envelope protein (rB2L) of orf virus.Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis.Neuroinvasion by scrapie following inoculation via the skin is independent of migratory Langerhans cells.Attenuated Salmonella typhimurium delivering DNA vaccine encoding duck enteritis virus UL24 induced systemic and mucosal immune responses and conferred good protection against challenge.Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin.Transfected human dendritic cells to induce antitumor immunity.Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism.Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter.Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.
P2860
Q28142802-97AB4109-4A89-48B9-AD18-5361B6001292Q28652580-31707998-EE5B-4EB4-BD70-8F9EA7F4BCDEQ30655322-37D89686-C044-4B2C-891C-4305A54F04A4Q33716181-38548511-3B87-4CC7-91B9-56224DF244A9Q33845229-50644DAF-298B-4352-A6B5-B0D4EE0C1672Q33849973-2455C128-CDB9-4412-BA76-03D804958022Q34058694-DDD3CCF4-899D-4531-97CD-C8D2B988ABFFQ34127421-AE68E828-F399-4191-8BA1-977DD46BA778Q34309830-FD181FF9-FB04-4B1F-8D07-798E1867A1C1Q34726060-D0F92EA2-ED2F-4A45-AA45-2D39CF9A602FQ34740663-16A90E26-DD59-457F-B6D6-F5351A12A4CAQ35790864-180A7C6F-2ECC-4934-96C8-D4A8C8B0114BQ35826399-4E845748-83C9-43C5-B893-7476F68EF9AAQ35848403-3D363137-40BA-4BB4-A7D1-6E5AABC1E7D5Q35890518-32283673-6C6D-4D29-8296-AC4111DBB668Q36303053-DCEFE16B-0453-4409-BAC7-091009F95E59Q36368444-8427F43A-A61E-4748-A218-705AE6A72EDBQ37202396-CC21CD36-DD30-425B-8242-AAA44443AF11Q37316018-4C5C36F2-8E12-4444-9DE6-70C7FBC727D3Q38247413-B8671687-1525-4249-B363-882A117C915AQ39014415-599E000D-F6B0-407A-8422-20D69C405040Q39970919-633E985A-6715-41D3-ADEF-C3EC97C0CD94Q40044935-097B9158-97F0-4B60-8109-880561F3BC7CQ40075918-0F121DB0-8D7E-4D2C-B9F2-137D01077583Q40568230-A04CF5DF-64C8-478B-841D-25DD44ECF5C8Q40893930-AD8E2DC0-A7A5-42D4-9647-5D4FF59D6A8DQ41952951-1FA8BA85-CD91-4E8B-9E72-63637EA6778CQ45862543-AF93772D-8B1F-4977-B991-942EC5834059Q45871048-F4FBA6F8-EBC9-49DB-9D76-B42569A41A7DQ45879294-95B7965E-1FD8-4B60-810C-CAE1EB44C674Q45884233-A8EB0216-12ED-4399-A80D-A4F909A488D1Q53044363-F87BB00E-899C-4A02-AE1E-265DF1664574
P2860
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
@ast
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
@en
type
label
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
@ast
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
@en
prefLabel
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
@ast
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
@en
P2093
P2860
P356
P1476
Quantitative analysis of the immunopotency of genetically transfected dendritic cells.
@en
P2093
Johnston SA
Takashima A
P2860
P304
13147-13152
P356
10.1073/PNAS.95.22.13147
P407
P577
1998-10-01T00:00:00Z